ARTICLE | Company News
Daiichi Sankyo sales and marketing update
June 9, 2014 7:00 AM UTC
Daiichi launched Efient prasugrel in Japan to treat patients with ischemic heart disease undergoing percutaneous coronary intervention (PCI). The National Health Insurance (NHI) price of the 3.75 mg ...